Home > Boards > US Listed > Medical - Drugs > BIOFRONTERA AG (BFRA)

Yesterday's run caught my eye. But after watching

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Pedro2004 Member Profile
 
Followed By 96
Posts 8,527
Boards Moderated 0
Alias Born 08/03/04
160x600 placeholder
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 4/8/2021 2:19:40 PM
Biofrontera provides preliminary revenue for 1Q21 Seeking Alpha - 4/8/2021 1:49:44 PM
Biofrontera announces preliminary revenue for Q1 2021 GlobeNewswire Inc. - 4/8/2021 10:30:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/31/2021 1:54:09 PM
Biofrontera announces conference call to be held on April 13, 2021 to discuss fiscal year 2020 financial results GlobeNewswire Inc. - 3/31/2021 10:12:43 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/31/2021 6:18:52 AM
Biofrontera submits application for FDA approval of new BF-RhodoLEDĀ® XL lamp GlobeNewswire Inc. - 3/31/2021 3:40:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/30/2021 7:22:17 AM
Humanigen, Universe Pharmaceuticals leads healthcare gainers; Millendo Therapeutics, Orphazyme among major losers Seeking Alpha - 3/29/2021 11:00:25 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/16/2021 6:22:23 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/4/2021 6:07:29 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/3/2021 2:53:12 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/3/2021 2:49:56 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/1/2021 1:10:00 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/26/2021 5:03:36 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/26/2021 10:29:20 AM
Biofrontera AG announces the closing of the capital raise with gross proceeds of EUR 24.7 million GlobeNewswire Inc. - 2/26/2021 9:20:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/25/2021 4:28:11 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 2/25/2021 4:06:58 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/25/2021 3:35:03 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/25/2021 11:13:16 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/25/2021 6:08:11 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/25/2021 6:07:19 AM
Biofrontera prices $8.9M public offering of ADS; shares down 8% Seeking Alpha - 2/24/2021 11:31:38 AM
Pedro2004   Wednesday, 08/12/20 07:47:44 AM
Re: Leebarooski post# 14
Post # of 25 
Yesterday's run caught my eye. But after watching the trading for a few hours yesterday and premarket today -- the run was being manipulated to dump shares.

Lol...you gotta love the single digit trades.

I think this is a scam company.

It is, what it is.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences